Literature DB >> 31397933

Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Stojan Peric1, Ivo Bozovic1, Marielle H J Pruppers2, Bogdan Bjelica1, Zorica Stevic1, Catharina G Faber2, Ingemar S J Merkies2,3, Ivana Basta1.   

Abstract

Inflammatory Rasch-built overall disability scale (I-RODS) seems to be a valid activity measure for use in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Our aim was to translate and validate the I-RODS for use in CIDP patients from Serbia. Study comprised 83 patients diagnosed with CIDP. I-RODS was translated and cross-culturally validated using the standard guidelines. Following scales were also administered: Medical Research Council (MRC) sum score, Inflammatory Neuropathy Cause and Treatment (INCAT) sensory and disability scores, Krupp's Fatigue Severity Scale, Beck Depression Inventory, Visual Analogue Scale for pain, and health survey-36 (SF-36) as a quality of life measure. According to the I-RODS, significant proportion of our patients reported that "running" (51%), "dancing" (41%), and "standing for hours" (40%) were impossible tasks to perform, while "teeth brushing" (94%), "eating" (88%), and "reading a newspaper/book" (82%) were noted as the easiest items. Patients with more muscle weakness (lower MRC sum score) and more severe INCAT sensory score had lower I-RODS score (P < .01). Also, patients with fatigue, depression and pain had lower I-RODS scores (P < .01). I-RODS score correlated with the INCAT disability score (P < 0.01) was 78 ± 19 compared to 51 ± 30 in patients with INCAT >1 (P < .01). I-RODS score correlated with the total SF-36 score (rho = +0.73, P < .01), as well as with all SF-36 domain scores. Serbian version of the I-RODS seems to be a valid activity measure for use in CIDP patients. I-RODS was able to assess different levels of disability, it was in association with impairment measures, INCAT disability scale and quality of life. Further studies are needed to assess its responsiveness.
© 2019 Peripheral Nerve Society.

Entities:  

Keywords:  I-RODS; chronic inflammatory demyelinating polyradiculoneuropathy; disability; impairment; quality of life; validation

Mesh:

Year:  2019        PMID: 31397933     DOI: 10.1111/jns.12343

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  2 in total

1.  A longitudinal evaluation of fatigue in chronic inflammatory demyelinating polyneuropathy.

Authors:  Karissa L Gable; Stojan Peric; Michael W Lutz; Ivo Bozovic; Milutin Petrovic; Aleksandar Stojanov; Ivana Basta; Jeffrey A Allen
Journal:  Brain Behav       Date:  2022-07-21       Impact factor: 3.405

2.  Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post-hoc analysis of the immunoglobulin overtreatment in CIDP trial.

Authors:  Robin van Veen; Luuk Wieske; Ilse Lucke; Max E Adrichem; Ingemar S J Merkies; Ivo N van Schaik; Filip Eftimov
Journal:  J Peripher Nerv Syst       Date:  2022-05-25       Impact factor: 5.188

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.